×
返回 Agendas
Asia Town Hall: Asia as a Drug R&D Center in the World
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor
SunFlare Co., Ltd, Japan
This session will address the current status of the regulatory environment as well as recent achievements and challenges of drug development in Asian countries.
Learning Objective : Recognize the current status and challenges of Asian regulators regarding international collaboration; Describe the importance and possibility of Asian countries as multiregional clinical trial centers; Discuss various Asian regulatory authorities regulatory environments.
Speaker(s)
Industry Perspective: Multiregional Clinical Trials Updates in Japan and Regulatory Convergence Among Asian Countries
Chitose Nishida
GlaxoSmithKline K.K., Japan
Department Manager of Regulatory Excellence
Updates of MRCT in Japan
Yuki Ando, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Senior Scientist for Biostatistics
Panelist
Silke Vogel, PhD
Duke NUS , Singapore
Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
注册方法
Registration override should work.